A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
EpiBiologics
EpiBiologics
Radiopharm Theranostics, Ltd
OHSU Knight Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Qilu Pharmaceutical Co., Ltd.
Onchilles Pharma Inc
OncoHost Ltd.
Shanghai Bao Pharmaceuticals Co., Ltd.
Sun Yat-sen University